
Metabolic Syndrome and Neurocognitive Deficits in HIV Infection
Author(s) -
Beverly C. Yu,
Elizabeth Pasipanodya,
Jessica L. Montoya,
Raeanne C. Moore,
Sara Gianella,
Allen McCutchan,
Ron R. Ellis,
Robert K. Heaton,
Dilip V. Jeste,
David J. Moore,
María Marquine
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000001964
Subject(s) - neurocognitive , medicine , cohort , comorbidity , verbal learning , population , neuropsychology , psychiatry , clinical psychology , cognition , environmental health
The adverse consequences of HIV and related comorbidities on the central nervous system remain prevalent in the era of combination antiretroviral therapy. Metabolic syndrome (MetS) is a common comorbidity in HIV and has been linked to increased neurocognitive impairment in the general population. We investigated the association between MetS and neurocognition among persons living with HIV (PLHIV).